Avidia

Avidia expands senior management team

Published in Pharma Investments, Ventures and Law Weekly, July 30th, 2006

Avidia, Inc., a privately-held biopharmaceutical company focused on discovering and developing a new class of human therapeutic proteins, announced the appointment of Paulette A. Dillon as senior vice president and chief business officer and Charles Sholtz, PhD, JD, as vice president of intellectual property and legal affairs.

"Avidia's therapeutic discovery programs have advanced to a stage in which partnerships and licensing are expected to add to the sustained value growth of the company. Paulette has the right background and experience to help us capitalize on the external interest in our programs," said Peter Van Vlasselaer, PhD, Avidia's chief executive officer....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-07-30)

More Articles from Pharma Investments, Ventures and Law Weekly

A.P. Pharma
Dutton Associates announces investment opinion update on A.P. Pharma
Adnexus Therapeutics
Adnexus Therapeutics closes $27 million series B funding
Aksys
Aksys closes investment by Durus
Angiotech
Angiotech Pharmaceuticals completes acquisition of Quill Medical
Auxilium
Auxilium files registration statement for previously issued securities
Barr
Barr announces offer of $2.2 billion for Pliva
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry